Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo.

Irie T, Fukushi K, Akimoto Y, Tamagami H, Nozaki T.

Nucl Med Biol. 1994 Aug;21(6):801-8.

PMID:
9234329
2.

N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.

Kikuchi T, Zhang MR, Ikota N, Fukushi K, Okamura T, Suzuki K, Arano Y, Irie T.

J Med Chem. 2005 Apr 7;48(7):2577-83.

PMID:
15801847
3.

Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates.

Namba H, Fukushi K, Nagatsuka S, Iyo M, Shinotoh H, Tanada S, Irie T.

Methods. 2002 Jul;27(3):242-50.

PMID:
12183113
4.
5.

Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.

Irie T, Fukushi K, Namba H, Iyo M, Tamagami H, Nagatsuka S, Ikota N.

J Nucl Med. 1996 Apr;37(4):649-55.

6.

Simplified methods for in vivo measurement of acetylcholinesterase activity in rodent brain.

Kilbourn MR, Sherman PS, Snyder SE.

Nucl Med Biol. 1999 Jul;26(5):543-50.

PMID:
10473193
7.

Syntheses of carbon-11 labeled piperidine esters as potential in vivo substrates for acetylcholinesterase.

Nguyen TB, Snyder SE, Kilbourn MR.

Nucl Med Biol. 1998 Nov;25(8):761-8.

PMID:
9863564
8.
9.
11.

Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.

Naik RS, Hartmann J, Kiewert C, Duysen EG, Lockridge O, Klein J.

J Pharm Pharm Sci. 2009;12(1):79-85.

12.

Developmental lead neurotoxicity: alterations in brain cholinergic system.

Reddy GR, Devi BC, Chetty CS.

Neurotoxicology. 2007 Mar;28(2):402-7. Epub 2006 Mar 29.

PMID:
16678265
13.

In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase.

Zatta P, Ibn-Lkhayat-Idrissi M, Zambenedetti P, Kilyen M, Kiss T.

Brain Res Bull. 2002 Oct 15;59(1):41-5.

PMID:
12372547
14.

Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.

Hartmann J, Kiewert C, Duysen EG, Lockridge O, Greig NH, Klein J.

J Neurochem. 2007 Mar;100(5):1421-9. Epub 2006 Dec 22.

15.

Regional specific alterations in brain acetylcholinesterase activity after repeated blast exposures in mice.

Valiyaveettil M, Alamneh Y, Oguntayo S, Wei Y, Wang Y, Arun P, Nambiar MP.

Neurosci Lett. 2012 Jan 6;506(1):141-5. doi: 10.1016/j.neulet.2011.10.067. Epub 2011 Nov 3.

PMID:
22079491
16.

In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog.

Namba H, Irie T, Fukushi K, Iyo M.

Brain Res. 1994 Dec 26;667(2):278-82.

PMID:
7697367
17.

In vitro phosphorylation of acetylcholinesterase at non-consensus protein kinase A sites enhances the rate of acetylcholine hydrolysis.

Grifman M, Arbel A, Ginzberg D, Glick D, Elgavish S, Shaanan B, Soreq H.

Brain Res Mol Brain Res. 1997 Nov;51(1-2):179-87.

PMID:
9427520
18.

A 1-methyl-4-piperidinyl cytectrene carboxylate labeled by the technetium 99m, a radiotracer for rat brain acetylcholinesterase activity.

Mejri N, Barhoumi C, Trabelsi M, Mekni A, Said NM, Saidi M.

Nucl Med Biol. 2010 Feb;37(2):143-8. doi: 10.1016/j.nucmedbio.2009.10.002. Epub 2009 Nov 5.

PMID:
20152713
19.

Syntheses and biological evaluation of (18)F-labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)propan-1-ones for in vivo mapping of acetylcholinesterase.

Choe YS, Oh S, Shim I, Naruto S, Chi DY, Kim SE, Lee K, Choi Y, Kim B.

Nucl Med Biol. 2000 Apr;27(3):263-7.

PMID:
10832083
20.

Supplemental Content

Support Center